NCT06528301 2026-01-12A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell MalignanciesUmoja BiopharmaPhase 1 Recruiting106 enrolled
NCT02790515 2025-08-12Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationSt. Jude Children's Research HospitalPhase 2 Active not recruiting170 enrolled
NCT04473911 2025-07-20Haplo Peripheral Blood Sct In GVHD PreventionMassachusetts General HospitalPhase 1 Completed25 enrolled
NCT00544115 2025-06-10Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical CenterPhase 2 Active not recruiting260 enrolled 13 charts